コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 and function of amelogenin, the predominant enamel matrix protein.
2 enamel, as well as the expression pattern of enamel matrix proteins.
3 ole for cathepsin K in degrading re-absorbed enamel matrix proteins.
4 rabony defects of various sizes treated with enamel matrix proteins.
5 Amelogenins bind to GlcNAc of the dentine-enamel matrix proteins.
6 dues in the Ser-x-Glu/pSer motifs in several enamel matrix proteins.
7 matrix components, and proteases processing enamel matrix proteins.
12 nin (AMELX) is the predominant extracellular enamel matrix protein and plays an essential role in ena
13 ve analysis may suggest a positive effect of enamel matrix proteins and a negative effect of DG used
14 ns constitute the major portion of secretory enamel matrix proteins and are known to be highly altern
16 tive (EMD) contains a variety of hydrophobic enamel matrix proteins and is extracted from developing
18 ects, one using extracellular matrix such as enamel matrix proteins and the other using growth factor
19 i.e., self-assembly, associations with other enamel matrix proteins and with calcium phosphate biomin
24 enamel probably by processing and regulating enamel matrix proteins around mineralization front appar
25 , we found that proteolysis of extracellular enamel matrix proteins by MMP20 is not required for the
26 h enamel matrix proteins (EMP group) or with enamel matrix proteins combined with bovine porous bone
28 eatment of intrabony defects treated with an enamel matrix protein derivative (EMD) combined with eit
30 ine bone mineral (DBBM) combined with either enamel matrix protein derivative (EMD) or collagen membr
33 The correct spatiotemporal patterning of enamel matrix protein (EMP) expression is fundamental to
34 meloblastin (AMBN), the second most abundant enamel matrix protein (EMP), plays a critical role in am
35 Intrabony defects were treated either with enamel matrix proteins (EMP group) or with enamel matrix
37 aluate the effectiveness of a combination of enamel matrix proteins (EMP), bovine porous bone mineral
38 -X-Y motif, the molecular mechanism by which enamel matrix proteins (EMPs) assemble into the organic
39 ntal defects can be achieved with the use of enamel matrix proteins (EMPs) or by grafting with bovine
42 ate, gene expression profiles of major tooth enamel matrix proteins (EMPs), amelogenin (AMELX), ename
43 have identified evidence that the genes for enamel matrix proteins (EMPs), milk caseins, and salivar
45 Mutations in ENAM, which encodes the largest enamel matrix protein, enamelin, have been demonstrated
46 loblastin (AMBN) is the second most abundant enamel matrix protein expressed during amelogenesis.
48 eviously reported that genes for three major enamel matrix proteins, five proteins necessary for dent
50 t data that support cooperative functions of enamel matrix proteins in mediating the structural hiera
51 Several studies have examined the role of enamel matrix proteins in root formation and periodontal
52 arding the potential role of the assembly of enamel matrix proteins in the regulation of crystal grow
54 ghly conserved AH motif is absent from other enamel matrix proteins, including amelogenin, enamelin,
56 work is needed to further incorporate other enamel matrix proteins into the system, this study bring
59 est that in addition to its role of cleaving enamel matrix proteins, MMP20 also cleaves junctional co
60 ta (AI) can be caused by the deficiencies of enamel matrix proteins, molecules responsible for the tr
61 d this technique to determine the effects of enamel matrix proteins on the gene activities of periodo
62 fect of DG used alone or in combination with enamel matrix proteins on the regeneration of Class III
65 assembly by helping to define the limits of enamel matrix protein-protein interactions that are beli
66 nt of various sized periodontal defects with enamel matrix proteins stimulated substantial periodonta
67 rmal cells that express transcripts encoding enamel matrix proteins, suggest hormonal control of epit
68 to investigate the adsorption properties of enamel matrix proteins to bone grafts after surface coat
69 , new tissue height was more similar between enamel matrix protein-treated defects and control defect
71 mm defects, the height of new cementum with enamel matrix protein treatment was 45% greater than the
74 the surface of bone grafting materials when enamel matrix proteins were delivered in either a liquid
75 neutral ethylene diamine tetracetic acid and enamel matrix proteins were used to treat the defects.
76 Amelogenins are a group of extracellular enamel matrix proteins which are believed to be involved